Table 3.
Prescription frequency of anti-hypertensive medications by type for all men (N = 173 prescriptions) and for men taking monotherapy (N = 90 prescriptions)
| All anti-hypertensive drugs (100 % of prescriptions) | Total | Monotherapy | Prescribed in Canada | |
|---|---|---|---|---|
| N | N | |||
| 173 | 90 | |||
| Thiazide Diuretics (3.5 % of total prescriptions) | Indapamide | 5 | 3 | Yes |
| Hydrochlorothiazide | 1 | -- | Yes | |
| Total | 6 | 3 | ||
| ACE-Inhibitors (42.8 % of total prescriptions) | Enalapril | 58 | 36 | Yes |
| Lisinopril | 7 | 5 | Yes | |
| Perindopril | 6 | 4 | Yes | |
| Captopril | 1 | -- | Yes | |
| Fosinopril | 1 | -- | Yes | |
| Ramipril | 1 | -- | Yes | |
| Total | 74 | 45 | ||
| ARBs (0.6 % of total prescriptions) | Losartan | 1 | -- | Yes |
| Total | 1 | 0 | ||
| Calcium-Channel Blockers (11.6 % of total prescriptions) | Nifedipine | 8 | 2 | Yes |
| Verapamil | 7 | 1 | Yes | |
| Amilodipine | 5 | 1 | Yes | |
| Total | 20 | 4 | ||
| β-Blockers (28.9 % of total prescriptions) | Metoprolol | 32 | 13 | Yes |
| Bisoprolol | 15 | 8 | Yes | |
| Propranolol | 2 | -- | Yes | |
| Carvediol | 1 | -- | Yes | |
| Total | 50 | 21 | ||
| Combination therapies (11.1 % of total prescriptions) | ||||
| ACE-Inhibitor & Diuretic (6.8 % of total prescriptions) | Perindopril & Indapamide | 8 | 7 | Yes |
| Enalapril & Indapamide | 1 | 1 | No. Drugs prescribed separately. | |
| Enalapril & Hydrochlorothiazide | 1 | -- | Yes | |
| Beta-Blocker & Diuretic (6.2 % of total prescriptions) | Atenolol & Chlortalidone | 9 | 8 | Yes |
| Total | 19 | 16 | ||
| α-Blockers (0.6 % of total prescriptions) | Clonidine | 1 | 1 | Yes |
| Total | 1 | 1 | ||
| Local Medications (1.2 % of total prescriptions) | Reserpine (Rauwolfia alkaloid) | 2 | -- | No. Drug not prescribed due to serious adverse side effects. |
| Total | 2 | 0 | ||